NCCN Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium The OlympiA trial showed a disease-free survival benefit with adjuvant PARP inhibitor therapy for early-stage, BRCA1/2-mutated, HER2-negative breast cancer patients. Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines The expert body now recognizes the test's ability to predict whether early-stage breast cancer patients will benefit from extended, adjuvant endocrine therapy. Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test The genomic test is covered by Medicare for all men with localized prostate cancer being considered for treatment. NCCN Updates Guidelines Advising Against Using Polygenic Risk Scores Outside of Clinical Trials The guidelines caution that there are "significant limitations" in the interpretation of polygenic risk scores and they should not be used in patient management. Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement Researchers concluded that there has been significant expansion of coverage for ctDNA assays over the past four years, but policies remain very heterogeneous and often limited. May 19, 2020 UMich Online Tool Aims to Improve Identification of Patients With Hereditary Cancer Risk Premium Mar 18, 2020 NCCN Backs Molecular Testing for Prostate Cancer Patients in Certain Risk Groups Dec 12, 2019 Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry Premium Dec 12, 2019 ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability Dec 4, 2019 NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk Nov 22, 2019 Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests Premium Feb 22, 2019 Genomic Health Stresses Oncotype DX Value After Questions Raised by Recent Study Premium Feb 7, 2019 Prostate Cancer Patients With Germline Variants Were Often Not Covered by Testing Guidelines Oct 10, 2018 NCCN Update on Breast Cancer Genetic Testing Guidelines Marks Oncotype DX as 'Preferred' Test Aug 3, 2018 Post-TAILORx, Genomic Health Tightens Focus on International Expansion Premium May 30, 2018 Exact Sciences Shares Rise Sharply on New Colorectal Cancer Screening Recommendation Feb 20, 2018 NCCN Updated Prostate Cancer Guidelines Include New Genetic Testing Information Nov 2, 2016 MDxHealth Posts Sharp Rise in Q3 Revenues Mar 2, 2016 MDxHealth Prostate Cancer Diagnostic Included in NCCN Early Detection Guidelines Oct 27, 2014 NCCN Mentions Prolaris, Oncotype DX in Updated Prostate Cancer Guidelines Oct 24, 2014 NCCN Including Use of VeriStrat in NSCLC Guidelines Oct 16, 2013 MDxHealth's MGMT Dx May Benefit from NCCN Support for Assessing Methylation Status in Glioblastoma Premium Aug 16, 2012 Will Insurers Cover $700 for Myriad's Large Rearrangement Test Plus $3K for BRACAnalysis? Premium Jul 25, 2012 Following CLIA Lab Buy, Life Tech Jumps into MDx Space with Purchase of Pinpoint, Lung Cancer Dx Premium Apr 18, 2012 ALK Mutation Testing for NSCLC on the Rise among Oncologists, BioTrends Survey Finds Premium Load More Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.